BIO-key International is trading 7.64% down at $2.90, with broad software-sector weakness the clearest available context, though no source directly attributes the move to it.
- No verified company-specific announcement on October 29 explains the decline.
- The October 28 Middle East government deployment was positive prior news, not a clear catalyst for todayβs drop.
- ServiceNow and Fortinet results weighed on software sentiment, with declines reported across software peers.